The consensus molecular subtypes of colorectal cancerJustin Guinney, Sabine Tejpar|Nature Medicine|2015Cited by 5.2k
Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomesSebastian Stintzing, Heinz‐Josef Lenz, Sabine Tejpar et al.|European Journal of Cancer|2017Cited by 293
Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trialSebastian Stintzing, Volker Heinemann, Florian Kaiser et al.|Annals of Oncology|2019Cited by 194
Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of responseChristopher J.M. Williams, Sabine Tejpar, Allyson Peddle et al.|Nature Reviews Clinical Oncology|2024Cited by 69
Societal challenges of precision medicine: Bringing order to chaosRoberto Salgado, Nils Wilking, Helen M. Moore et al.|European Journal of Cancer|2017Cited by 29